← All companies

OKYO

OKYO Pharma Limited

OKYO Nasdaq Biological Products, (No Diagnostic Substances) EDGAR ↗

$1.67

+0.01 +0.60%

Key statistics

from XBRL data in SEC filings

Market cap

$87.6M

Revenue (TTM)

—

Net income (TTM)

—

EPS (TTM)

—

P/E ratio

—

Dividend yield

—

Free cash flow

—

Cash

—

Total assets

—

Gross margin

—

52-week range

$1.34 – $3.35

Recent SEC filings

40 most recent

Annual, quarterly & current reports

6-K Jul 28, 2026 6-K Jul 27, 2026 6-K Jul 23, 2026 6-K Jul 23, 2026 6-K Jul 22, 2026 6-K Jul 22, 2026 6-K Jul 22, 2026 6-K Jul 21, 2026 6-K Jul 21, 2026 6-K Jul 20, 2026 20-F Jul 20, 2026 6-K Jul 8, 2026 6-K Jul 7, 2026 6-K May 19, 2026 6-K Apr 29, 2026 6-K Apr 7, 2026 6-K Mar 19, 2026 6-K Mar 19, 2026 6-K Mar 19, 2026 6-K Mar 18, 2026 6-K Mar 12, 2026 6-K Feb 23, 2026 6-K Feb 13, 2026 6-K Feb 13, 2026 6-K Feb 12, 2026 6-K Feb 11, 2026 6-K Feb 11, 2026 6-K Feb 10, 2026 6-K Jan 30, 2026 6-K Jan 30, 2026 6-K Jan 28, 2026 6-K Jan 23, 2026 6-K Jan 5, 2026 6-K Dec 19, 2025 6-K Dec 15, 2025 6-K Dec 11, 2025 6-K Dec 3, 2025 6-K Nov 21, 2025 6-K Nov 18, 2025 6-K Oct 29, 2025